Leadership & People
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Executives On The Move: Abivax Aquires Chief Medical Officer From Landos Biopharma And Gets a New Chief Strategy Officer
Recent moves in the industry include C-suite shuffles at AbbVie, Abivax and Ikena Oncology, plus I-Mab.
McKinsey Finds Global Business Leaders Most Worried About Geopolitics, China Slowdown
Growing geopolitical tensions and a slowing Chinese economy are among the topmost concerns for global business leaders across sectors, a McKinsey study has shown. Separately, in pharma, the BIOSECURE Act continues to occupy centre stage with US House Speaker Johnson recently pledging to push China-targeted legislation before House elections in November
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Q1’s top 10 drugs; Pfizer’s R&D leadership succession; Lilly bolsters IBD pipeline; first half deal volume up but value down; and EU firms’ China sentiment plummets.
Executives On The Move: Three New CEOs Among This Week's Changes
Recent moves in the industry include C-suite shuffle at Armis Biopharma, plus Voyager Therapeutics acquires chief financial officer from Vor Biopharma.
Pfizer’s Dolsten Plans Exit, Ushering In R&D Transition
Chief scientific officer and president of Pfizer Research & Development Mikael Dolsten will depart the company after a successor is appointed, likely early next year.
UK Life Sciences Leaders Optimistic After Labour Landslide
However, the country's pharma association says that the new government "needs to hit the ground running and rapidly set out a clear, detailed plan" for what it will do in the coming weeks and years.
Executives On The Move: Three New CFOs Among This Week's C-Suite Changes
Recent moves in the industry include changes at the top at AbbVie, Regenxbio and Keros Therapeutics, plus Merus acquires a chief medical officer from ImmunoGen. Y-mAbs Therapeutics hires a chief financial officer from Voyager Therapeutics.
India Pharma Chiefs On Supply Chain Learnings From Auto Sector, New ‘PAGE’ On Skilling
Leaders from India’s top drug makers discuss efforts to operationalize a world-class skilling institute, backed by tie-ups with organizations like the PDA, ISPE and also taking a leaf out of the automobile industry’s book to build supply chain resilience. They also exuded confidence on moving up the innovation value chain.
Executives On The Move: Arvinas Nabs New Chief Financial Officer From Intercept Pharmaceuticals
Recent moves in the industry include changes at the top for Sumitomo Pharma, ASKA and Takeda, plus Maat Pharma gets a new chief medical officer.
Parexel Execs On Obesity Drug Hurdles, Parexel GPT, India RWD Opportunity
Parexel’s chief strategy officer Kushal Gohil, Clinical EVP Stephen Pyke and India head Sanjay Vyas share thoughts on possible hurdles to, and the cascading impact of obesity treatments, GenAI progress and the opportunities and challenges of real-world data in India, in the second of this two-part interview with Scrip.
Titans Of Pharma: J&J Back On Top For CEO Remuneration
J&J topped the league table for CEO pay in 2023, a position it has held for three of the four past years. Meanwhile, the two companies that arguably generated the most buzz in 2023 neatly depict the stark contrast between the US and Europe when it comes to executive remuneration.
Executives On The Move: New Hires At Eisai, Connect Biopharma, Actylis And More
Recent moves in the industry include new chief executive officers at Connect Biopharma, Skyhawk Therapeutics and Actylis, plus I-Mab gets new chief medical officer.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.